arrow
E

Elisa De Paolis

fondazione policlinico gemelli irccs
H指数:14
被引数:540

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer

BRCA拷贝数改变在商业HRD检测中的增强检测:对卵巢癌精准肿瘤学的意义

2026-04-290
OAAI
Detection of Clinically Significant BRCA Large Genomic Rearrangements in FFPE Ovarian Cancer Samples: A Comparative NGS Study

临床意义显著BRCA大基因组重排的检测:一项比较NGS研究(在FFPE卵巢癌样本中)

2025-10-010
OAAI
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer

根据分子靶点临床可操作性量表(ESCAT)评估的,无特定分子特征(NSMP)子宫内膜癌的基因可操作性

2025-09-030
OAAI
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib

NRG1变异体不确定意义(VUSes)在晚期非小细胞肺癌中的网络分析及其在EGFR突变患者接受一线奥希替尼治疗中的预后作用

2025-08-290
OAAI
Management Of A Patient With Ovarian Cancer Carried Of The BRCA2 P.R3052Q Variant: From Tissue To Liquid Biopsy To Clarify The Molecular Status Of The Patient

携带BRCA2 P.R3052Q变异的卵巢癌患者管理:从组织活检到液体活检,以明确患者的分子状态

2025-02-010
PRE
Identification of a False-positive Multiplex Ligation- dependent Probe Amplification Result in BRCA1 Using a Copy Number Variation Algorithm Under Development for a Commercial Next-Generation Sequencing-based Homologous Recombination Deficiency Assay
2024-05-310
OAAI
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study (vol 23, 540, 2023)
2023-11-090
OAAI
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

肺癌多组学数字人体化身将精准医学融入临床实践: 灯笼研究

2023-06-1313
OAAI
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine

评估未知意义的BRCA1/2变异的致病性: 乳腺癌精准医学的相关性和挑战

2023-01-185
OAAI